Share:
ULI Asia Pacific Thought Leadership Webinar Series: A New Era of Life Sciences Growth - Opportunities for Occupiers and Investors
This webinar is complimentary and open to all. Registration is required.
Burgeoning demand for pharmaceuticals from a large and ageing population; government pro-growth policies to support the industry; a steady flow of M&A activity; a rising number of IPOs; and the expansion of R&D capacity are just a few of the factors fueling occupier demand for life sciences real estate in Asia Pacific.
More recently, the life sciences industry’s role at the forefront of combatting the COVID-19 pandemic has generated substantial requirements for real estate to test, produce and store vaccines, medicines, and related products, adding to already significant demand.
As these powerful macro trends converge, CBRE is tracking a rise in interest from investors eyeing an asset class that until recently was some way down the list of preferred alternative sectors for investment.
Join us for this edition of the ULI Thought Leadership Webinar Series, where our Corporate Partner CBRE will provide an overview of Asia Pacific life sciences real estate, focusing on the key trends, demand drivers, corporate real estate strategies and investment opportunities in the region’s major life sciences hubs.
More recently, the life sciences industry’s role at the forefront of combatting the COVID-19 pandemic has generated substantial requirements for real estate to test, produce and store vaccines, medicines, and related products, adding to already significant demand.
As these powerful macro trends converge, CBRE is tracking a rise in interest from investors eyeing an asset class that until recently was some way down the list of preferred alternative sectors for investment.
Join us for this edition of the ULI Thought Leadership Webinar Series, where our Corporate Partner CBRE will provide an overview of Asia Pacific life sciences real estate, focusing on the key trends, demand drivers, corporate real estate strategies and investment opportunities in the region’s major life sciences hubs.